(Q30864899)

27 June 2017

Increased anti-streptococcal antibodies in patients with Tourette's syndrome (English)

1 reference

27 June 2017

1 reference

1 reference

Müller N

1

1 reference

27 June 2017

Riedel M

2

1 reference

27 June 2017

Straube A

3

1 reference

27 June 2017

Günther W

4

1 reference

27 June 2017

Wilske B

5

1 reference

27 June 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

27 June 2017

1 reference

27 June 2017

94

1 reference

27 June 2017

1

1 reference

27 June 2017

43-49

1 reference

Case study: a new infection-triggered, autoimmune subtype of pediatric OCD and Tourette's syndrome

27 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900125-6

7 January 2021

A follow-up study of Sydenham's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900125-6

7 January 2021

Gilles de la Tourette's syndrome. A postmortem neuropathological and immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900125-6

7 January 2021

Tourette's syndrome and 'PANDAS': will the relation bear out? Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900125-6

7 January 2021

Elevated IgG titer against the C region of streptococcal M protein and its immunodeterminants in patients with poststreptococcal acute glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900125-6

7 January 2021

Immunoglobulintherapie bei Gilles-de-la-Tourette-Syndrom

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900125-6

7 January 2021

Characteristics of obsessive-compulsive symptoms in Tourette's syndrome, obsessive-compulsive disorder, and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900125-6

7 January 2021

B lymphocyte antigen D8/17: a peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette's syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900125-6

7 January 2021

Chronic dopaminergic sensitivity after Sydenham's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900125-6

7 January 2021

Reduced basal ganglia volumes in Tourette's syndrome using three-dimensional reconstruction techniques from magnetic resonance images

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900125-6

7 January 2021

Lyme disease presenting as Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900125-6

7 January 2021

Tic disorders: new developments in Tourette syndrome and related disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900125-6

7 January 2021

Neurobiological issues in Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900125-6

7 January 2021

Volumetric MRI changes in basal ganglia of children with Tourette's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900125-6

7 January 2021

Antibodies against human putamen in children with Tourette syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900125-6

7 January 2021

Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900125-6

7 January 2021

Tourette's disorder: is there an association with the antiphospholipid syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900125-6

7 January 2021

10.1016/S0165-1781(00)00125-6

Identifiers

DOI

1 reference

27 June 2017

1 reference